Variant-specific treatment gaps: Evaluating the low use of tocilizumab and enoxaparin in omicron ICU cases

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan; Kaeshaelya Thiruchelvam

doi:10.1016/j.jfma.2024.12.013

Variant-specific treatment gaps: Evaluating the low use of tocilizumab and enoxaparin in omicron ICU cases

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	476-477
Number of pages	2
Journal	Journal of the Formosan Medical Association
Volume	124
Issue number	5
Early online date	19 May 2025
DOIs	https://doi.org/10.1016/j.jfma.2024.12.013
Publication status	Published - 19 May 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jfma.2024.12.013Licence: CC BY

Cite this

@article{00d5808fd71c438593fa75e6cd325e3c,

title = "Variant-specific treatment gaps: Evaluating the low use of tocilizumab and enoxaparin in omicron ICU cases",

keywords = "Anticoagulant, Coronavirus, Heparin, IL-6, Interleukin",

author = "Kow, \{Chia Siang\} and Ramachandram, \{Dinesh Sangarran\} and Hasan, \{Syed Shahzad\} and Kaeshaelya Thiruchelvam",

year = "2025",

month = may,

day = "19",

doi = "10.1016/j.jfma.2024.12.013",

language = "English",

volume = "124",

pages = "476--477",

journal = "Journal of the Formosan Medical Association",

issn = "0929-6646",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - Variant-specific treatment gaps

T2 - Evaluating the low use of tocilizumab and enoxaparin in omicron ICU cases

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

AU - Thiruchelvam, Kaeshaelya

PY - 2025/5/19

Y1 - 2025/5/19

KW - Anticoagulant

KW - Coronavirus

KW - Heparin

KW - IL-6

KW - Interleukin

UR - https://www.scopus.com/pages/publications/85215086104

U2 - 10.1016/j.jfma.2024.12.013

DO - 10.1016/j.jfma.2024.12.013

M3 - Letter

C2 - 39665935

AN - SCOPUS:85215086104

SN - 0929-6646

VL - 124

SP - 476

EP - 477

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

IS - 5

ER -

Variant-specific treatment gaps: Evaluating the low use of tocilizumab and enoxaparin in omicron ICU cases

UN SDGs

Access to Document

Other files and links

Cite this